These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22287651)

  • 21. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
    Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
    Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D
    AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Ki-67 and p53 in meningiomas.
    Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
    Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A5: a marker of recurrence in WHO grade I meningiomas.
    Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
    Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningiomas: correlation of Ki67 with histological grade.
    Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
    Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
    Hernández Faraco A; Céspedes G; Trejo E
    Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of morphologically benign biologically aggressive meningiomas.
    Rao S; Sadiya N; Doraiswami S; Prathiba D
    Neurol India; 2009; 57(6):744-8. PubMed ID: 20139503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
    Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
    Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The expression and significance of apoptosis related gene BAG-1 in meningioma].
    Zhou KY; Jin HH; Zhou T; Luo YK
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Mar; 29(2):110-3. PubMed ID: 23833958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
    Takei H; Buckleair LW; Powell SZ
    Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKT2 expression in histopathologic grading and recurrence of meningiomas.
    Wang Q; Fan SY; Qian J; Wang JY; Lu YC; Hu GH; Luo C
    Eur J Surg Oncol; 2014 Sep; 40(9):1056-61. PubMed ID: 24656454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
    Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
    Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caveolin-1 in meningiomas: expression and clinico-pathological correlations.
    Barresi V; Cerasoli S; Paioli G; Vitarelli E; Giuffrè G; Guiducci G; Tuccari G; Barresi G
    Acta Neuropathol; 2006 Nov; 112(5):617-26. PubMed ID: 16850311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical study of MRP5 expression in meningiomas.
    Alexiou GA; Goussia A; Ntoulia A; Zagorianakou P; Malamou-Mitsi V; Voulgaris S; Kyritsis AP
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):825-8. PubMed ID: 23271324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 Protein expression in meningiomas - a clinicopathologic study of 55 patients.
    Aguiar PH; Agner C; Simm R; Freitas AB; Tsanaclis AM; Plese P
    Neurosurg Rev; 2002 Aug; 25(4):252-7. PubMed ID: 12172734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
    Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J
    APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
    Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
    Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.